The toll of the COVID-19 pandemic was reflected in a natural decrease during 2021 in the population of nearly three-quarters of U.S. counties versus the two previous years, the census bureau said on March 24.
After a disappointing end to a nine-year trial, the U.S. Food and Drug Administration officially gave AMAG Pharmaceuticals notice of the proposal to withdraw approval of Makena, an injectable progestin treatment to reduce preterm births.
Pregnant women are no more likely to become severely ill with COVID-19 than other women, according to a preliminary study in Britain, but most expectant mothers who do develop serious illness tend to be in the later stages of pregnancy.
Acadia Pharmaceuticals Inc. and Neuren Pharmaceuticals Limited announced that the U.S. Food and Drug Administration granted Rare Pediatric Disease designation to trofinetide for the treatment of Rett syndrome, a serious and rare neurological disorder.
The number of babies born in Japan fell an estimated 5.9 percent during 2019 to fewer than 900,000 for the first time since the government started compiling data in 1899.
For Halloween, BioSpace collected six tales of thrills and chills from the pharma and biotech industries that will surely have you covering your eyes in terror.
The U.S. Food and Drug Administration approved South African drugmaker Aspen Pharmacare’s hydroxyprogesterone caproate (HPC), which is used to prevent preterm birth in pregnant women.
Shares of AMAG Pharmaceuticals plunged after the company’s Phase III PROLONG trial of Makena failed to show a statistically significant difference from placebo in preventing preterm births.
Fewer babies were born in Italy in 2015 than in any year since the modern state was founded 154 years ago, and the population shrank for the first time in […]
President Obama wants you to know: He loves America’s seniors. (And is even intimidated by a few of them.) “The toughest justice on the Supreme Court is also the oldest … […]